Cargando…

FGF-21 levels in polyuria-polydipsia syndrome

The pathomechanism of primary polydipsia is poorly understood. Recent animal data reported a connection between fibroblast growth factor 21 (FGF-21) and elevated fluid intake independently of hormonal control by the hormone arginine-vasopressin (AVP) and osmotic stimulation. We therefore compared ci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Refardt, Julie, Sailer, Clara Odilia, Winzeler, Bettina, Betz, Matthias Johannes, Chifu, Irina, Schnyder, Ingeborg, Fassnacht, Martin, Fenske, Wiebke, Christ-Crain, Mirjam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311457/ https://www.ncbi.nlm.nih.gov/pubmed/30592707 http://dx.doi.org/10.1530/EC-18-0469

Ejemplares similares

Validity of different copeptin assays in the differential diagnosis of the polyuria-polydipsia syndrome
por: Sailer, Clara Odilia, et al.
Publicado: (2021)

Validity of Different Copeptin Assays in the Differential Diagnosis of the Polyuria-Polydipsia Syndrome
por: Sailer, Clara Odilia, et al.
Publicado: (2021)

GLP1 Receptor Agonists Reduce Fluid Intake in Primary Polydipsia
por: Winzeler, Bettina Felicitas, et al.
Publicado: (2021)

Oxytocin Levels in Response to Pituitary Provocation Tests in Healthy Volunteers
por: Sailer, Clara Odilia, et al.
Publicado: (2021)

EJE AWARD 2019: New diagnostic approaches for patients with polyuria polydipsia syndrome
por: Christ-Crain, Mirjam
Publicado: (2019)

Incidence of hyperkalemia during hypertonic saline test for the diagnosis of diabetes insipidus
por: Potasso, Laura, et al.
Publicado: (2021)

Markers of systemic inflammation in response to osmotic stimulus in healthy volunteers
por: Sailer, Clara Odilia, et al.
Publicado: (2019)

Olanzapine: Polyuria and polydipsia: case report
Publicado: (2021)

THU113 Psychopathological Characteristics In Patients With Arginine Vasopressin Deficiency (Central Diabetes Insipidus) And Primary Polydipsia
por: Beck, Julia, et al.
Publicado: (2023)

Copeptin is not useful as a marker of malignant disease in the syndrome of inappropriate antidiuresis
por: Winzeler, Bettina, et al.
Publicado: (2019)

Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis
por: Refardt, Julie, et al.
Publicado: (2019)

Approach to the Patient: “Utility of the Copeptin Assay”
por: Christ-Crain, Mirjam, et al.
Publicado: (2022)

A 27-Month-Old Boy with Polyuria and Polydipsia
por: Lee, Yvonne, et al.
Publicado: (2018)

Genetic deletion of connexin 37 causes polyuria and polydipsia
por: Xue, Jianxiang, et al.
Publicado: (2020)

Polydipsia and polyuria at high environmental temperature in association with the productive traits in the fowl
por: Obeidah, A, et al.
Publicado: (1977)

RF25 | PMON179 Role of Apparent Strong Ion Difference in the Differential Diagnosis of Thiazide Associated Hyponatremia
por: Monnerat, Sophie, et al.
Publicado: (2022)

Polyuria and polydipsia revealing a pituitary metastasis: Report of a rare case
por: Gader, Ghassen, et al.
Publicado: (2022)

Empagliflozin Increases Short-Term Urinary Volume Output in Artificially Induced Syndrome of Inappropriate Antidiuresis
por: Refardt, Julie, et al.
Publicado: (2017)

OR20-06 Diagnosing Central Diabetes Insipidus Using Copeptin Upon Hypertonic Saline Versus Arginine Stimulation
por: Refardt, Julie, et al.
Publicado: (2023)

The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study
por: Atila, Cihan, et al.
Publicado: (2022)

Chloride and Potassium Assessment Is a Helpful Tool for Differential Diagnosis of Thiazide-Associated Hyponatremia
por: Potasso, Laura, et al.
Publicado: (2023)

OR27-6 Effects of the SGLT2-Inhibitor Empagliflozin in Patients With Chronic Syndrome of Inadequate Antidiuresis (SIAD) - Results of a Double-Blind, Randomized, Placebo-Controlled, Crossover Trial
por: Berres, Manfred, et al.
Publicado: (2022)

A Pilot Randomized Trial to Compare Polyuria and Polydipsia during a Short Course of Prednisolone or Methylprednisolone in Dogs with Atopic Dermatitis
por: Lokianskiene, Viktorija, et al.
Publicado: (2022)

Prevalence of Admission Hyponatremia in Patients With Diabetes Treated With and Without an SGLT2 inhibitor
por: Monnerat, Sophie, et al.
Publicado: (2023)

OR2805 Plasma Sodium Increase Is Associated With An Increase In Bone Formation In Outpatients With Chronic SIAD—A Predefined Secondary Analysis Of The SANDx Trial
por: Monnerat, Sophie, et al.
Publicado: (2023)

Polyuria
Publicado: (1908)

Psychogenic Polydipsia
por: Kohli, Ajay, et al.
Publicado: (2011)

Case of Polydipsia
por: Ware, John
Publicado: (1816)

An Increase in Plasma Sodium Levels Is Associated With an Increase in Osteoblast Function in Chronic SIAD
por: Monnerat, Sophie, et al.
Publicado: (2023)

Polyuria in Sciatica
Publicado: (1910)

Hyponatremia Intervention Trial (HIT): Study Protocol of a Randomized, Controlled, Parallel-Group Trial With Blinded Outcome Assessment
por: Refardt, Julie, et al.
Publicado: (2021)

Copeptin levels and commonly used laboratory parameters in hospitalised patients with severe hypernatraemia - the “Co-MED study”
por: Nigro, Nicole, et al.
Publicado: (2018)

A 75-Year-Old Woman with a 5-Year History of Controlled Type 2 Diabetes Mellitus Presenting with Polydipsia and Polyuria and a Diagnosis of Central Diabetes Insipidus
por: Ohara, Nobumasa, et al.
Publicado: (2022)

OR17-01 Novel Provocation Test With MDMA (‘Ecstasy’) Reveals Oxytocin Deficiency As A New Pituitary Entity In Patients With Central Diabetes Insipidus - A Randomized Placebo-Controlled Trial
por: Atila, Cihan, et al.
Publicado: (2023)

Polyuria following an overdose
por: Collins, Angela, et al.
Publicado: (2013)

An unusual cause of polyuria
por: Muthukrishnan, Jayaraman, et al.
Publicado: (2012)

Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome
por: Ebrahimi, Fahim, et al.
Publicado: (2021)

Dr. Domeier, on the Cure of Polydipsia
por: Domeier, W.
Publicado: (1800)

Psychogenic Polydipsia – Management Challenges
por: BHATIA*, M.S., et al.
Publicado: (2017)

Acetazolamide: Treatment of Psychogenic Polydipsia
por: Ahmed, Syed E, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_aqoqhono5o35f0nql3mufkfsbs